resources

Alivus Life Sciences Ltd.

NSE: ALIVUS

BSE: 543322

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

1,362.60-3.5 (-0.26%)

25 Aug, 9:29 AM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Alivus Life Sciences Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2021	2022	2023	2024	2025	2026
Annual Reports	—	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Quarterly Results	Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun
Conference Calls	—	5Aug 8Aug 22Oct 27Oct	28Jan 1Feb 2May 24Jul 25Oct	31Jan 3May 2Aug	23May 8Aug 13Nov	30Jan 21May 7Aug
Presentations	10Nov	8Feb 20Apr 4Aug 21Oct 17Nov	27Jan 27Apr 21Jul 20Oct	23Jan 11Mar 25Apr 25Jul 24Oct	23Jan 15May 1Aug 6Nov	22Jan 14May 30Jul

Corporate Announcements and Regulatory Filings

Alivus Life Sciences Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

Press Release / Media Release18 Aug 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Enclosed please find herewith Press Release with respect to Acquisition.
Acquisition18 Aug 2026
Announcement under Regulation 30 (LODR)-Acquisition
Enclosed please find herewith intimation pursuant to Regulation 30 of SEBI (LODR), 2015 with respect to acquisition.
Analyst / Investor Meet13 Aug 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - Intimation of Investors/Analyst Meeting
Newspaper Publication13 Aug 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed herewith Newspaper Advertisement of Notice of 15th Annual General Meeting and E-Voting information.
Business Responsibility and Sustainability Reporting (BRSR)11 Aug 2026
Business Responsibility and Sustainability Reporting (BRSR)
Please find enclosed herewith the Business Responsibility & Sustainability Report for FY 2025-26
Reg. 34 (1) Annual Report11 Aug 2026
Reg. 34 (1) Annual Report.
Please find enclosed herewith Integrated Annual Report FY 2025-26 under Regulation 34 (1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
AGM11 Aug 2026
Notice Of 15Th Annual General Meeting Of The Company For FY 2025-26 As Required Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Please find attached herewith Notice convening the 15th Annual General Meeting.
Analyst / Investor Meet7 Aug 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Enclosed please find herewith details of investor meet.
Analyst / Investor Meet7 Aug 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Please find attached herewith details of Analyst/Investor meet.
Newspaper Publication6 Aug 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement for 15th Annual General Meeting (AGM)
Record Date6 Aug 2026
Intimation Of Record Date For Dividend
Intimation of Record date for Dividend.
AGM6 Aug 2026
Intimation Of 15Th Annual General Meeting And Record Date.
Intimation of 15th Annual General Meeting and Record date.
Analyst / Investor Meet31 Jul 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
We hereby confirm that we have uploaded audio recording of the Q1 FY2027 Earnings Call held on July 31, 2026 on the website of the Company.
Allotment of ESOP / ESPS30 Jul 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Enclosed please find herewith intimation with respect to allotment of equity shares under ''Employee Stock Options Scheme, 2021''
Press Release / Media Release30 Jul 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Enclosed please find herewith Press Release of the Company for the first quarter ended June 30, 2026.
Outcome of Board Meeting30 Jul 2026
Board Meeting Outcome for Unaudited Financial Results For The First Quarter Ended June 30, 2026
Enclosed please find herewith unaudited financial results for the first quarter ended June 30, 2026.
Analyst / Investor Meet23 Jul 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Enclosed please find herewith the details of Earnings Call slated for Friday, July 31, 2026 from 8:30 a.m. to 9:30 a.m. (IST), for your information and record.
Closure of Trading Window23 Jul 2026
Closure of Trading Window
Intimation of closure of Trading Window from 1st July, 2026 to 1st August, 2026 (both days inclusive), for the purpose of approval of unaudited financial results for the quarter ended 30th June, 2026.
Board Meeting23 Jul 2026
Board Meeting Intimation for Considering And Approving Unaudited Financial Results Of The Company For The Quarter Ended 30Th June, 2026.
Alivus Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2026 ,inter alia, to consider and approve the Unaudited Financial ....
Analyst / Investor Meet23 Jun 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - Intimation of Institutional Investor Meeting - Plant Visit

Frequently Asked Questions

Where can I download the annual report of Alivus Life Sciences Ltd.?

Annual reports of Alivus Life Sciences Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Alivus Life Sciences Ltd.?

Quarterly earnings results and presentations of Alivus Life Sciences Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Alivus Life Sciences Ltd. publish earnings call transcripts?

Earnings call transcripts of Alivus Life Sciences Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Alivus Life Sciences Ltd.?

Investor presentations and annual day presentations of Alivus Life Sciences Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Alivus Life Sciences Ltd.?

Corporate announcements and regulatory filings of Alivus Life Sciences Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Alivus Life Sciences Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Alivus Life Sciences Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Alivus Life Sciences Ltd.?

The ISIN (International Securities Identification Number) of Alivus Life Sciences Ltd. is INE03Q201024. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Alivus Life Sciences Ltd. listed?

Alivus Life Sciences Ltd. is listed on NSE and BSE. The NSE symbol is GLS and the BSE code is -.

Where can I find the shareholding pattern of Alivus Life Sciences Ltd.?

The quarterly shareholding pattern of Alivus Life Sciences Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Alivus Life Sciences Ltd. on Sharpely?

Share price data for Alivus Life Sciences Ltd. is updated as of 25 Aug 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.